PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers - Sorbonne Université
Journal Articles World Journal of Urology Year : 2021

PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers

Abstract

Background Atezolizumab is an inhibitor of programmed death-ligand 1 (PD-L1), used to treat advanced or metastatic bladder cancer, and in trials for non-invasive disease. In order to be eligible for treatment, patients require a PD-L1 immune cell score ≥ 5%, using the Ventana SP142 PD-L1 assay. Many laboratories do not have access to the required Ventana Benchmark Ultra stainer, and it is unclear if the assay performs similarly on other stainers. In this study, we compare SP142 assay results between Ventana Benchmark Ultra and Leica Bond-III stainers. Methods Serial sections of 90 samples of transurethral bladder resections (comprising 51 pTaHG, 8 pTis, 18 pT1, 10 pT2 tumors) were stained using the SP142 PD-L1 antibody on Ventana Benchmark Ultra and Leica Bond-III stainers, manually scored, and compared using accuracy and Cohen's kappa measures. Results Both devices yielded highly concordant PD-L1 immune cell scores (accuracy 0.84, Cohen's κ 0.732). Moreover, we found similar tumor cell (TC) PD-L1 scores using both stainers, and a trend towards greater TC scores in pT2 stage samples (p = 0.05). Conclusion This study is the first to compare the SP142 antibody in bladder cancer on two different stainers. Our results indicate that both Benchmark Ultra and Bond-III stainers yield highly concordant results using the SP142 PD-L1 antibody.

Domains

Cancer
Fichier principal
Vignette du fichier
Compérat2021_Article_PD-L1SP142TestingIsConcordantB.pdf (684.74 Ko) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03352945 , version 1 (23-09-2021)

Identifiers

Cite

Eva Compérat, André Oszwald, Gabriel Wasinger, Justine Wacquet, Morgan Rouprêt, et al.. PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers. World Journal of Urology, 2021, ⟨10.1007/s00345-021-03828-w⟩. ⟨hal-03352945⟩
25 View
21 Download

Altmetric

Share

More